Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy

Clinical trial NCT05673850 · COMPLETED

Trial details

NCT number: NCT05673850
Sponsor: Peking University
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2022-05-01
Primary completion: 2022-08-01
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.